Expansion of NKG2C-expressing Natural Killer Cells after Umbilical Cord Blood Transplantation in a Patient with Peripheral T-cell Lymphoma with Cytotoxic Molecules

Intern Med. 2018 Mar 15;57(6):861-866. doi: 10.2169/internalmedicine.9437-17. Epub 2017 Dec 21.

Abstract

A 64-year-old woman presented with generalized lymphadenopathy and systemic manifestations. The examination of a biopsy specimen revealed peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) expressing cytotoxic molecules. Umbilical cord blood transplantation was successful during a partial remission state after the administration of salvage chemotherapy. The donor-derived large granular lymphocytes started to increase as a result of cytomegalovirus reactivation. The fraction of natural killer (NK) cells expressing the NKG2C molecule accounted for one-third of the total lymphocytes for almost two years. We implicitly indicate the association between the persistence of donor-derived NKG2C+ NK cell-expansion and maintaining a complete remission in similar cases of aggressive PTCL-NOS.

Keywords: natural killer cell; peripheral T-cell lymphoma not otherwise specified; umbilical cord blood transplantation.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Fetal Blood / transplantation*
  • Humans
  • Killer Cells, Natural / immunology*
  • Lymphoma, T-Cell, Peripheral / immunology*
  • Lymphoma, T-Cell, Peripheral / therapy*
  • Middle Aged
  • NK Cell Lectin-Like Receptor Subfamily C / genetics*
  • Peripheral Blood Stem Cell Transplantation / methods*
  • Treatment Outcome

Substances

  • KLRC2 protein, human
  • NK Cell Lectin-Like Receptor Subfamily C